Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 911-915-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.418 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 5
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 2.09 mg/m³
- Explanation for the modification of the dose descriptor starting point:
There are no relevant experimental data on repeated exposure by inhalation. A conservative approach is used assuming a two times higher absorption via the inhalation route (end route) as compared to the oral route (starting route).
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 1
- Justification:
- No time extrapolation factor is needed since a chronic toxicity study is available.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Respiratory interspecies differences are fully covered by the factors used for route to route extrapolation.
- AF for other interspecies differences:
- 1
- Justification:
- There is no evidence for species differences in the general mode of action or kinetics.
- AF for intraspecies differences:
- 5
- Justification:
- The default value for the relatively homogenous group "worker" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.43 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 7
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 10 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Please refer to expalantion on hazard conclusion.
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 1
- Justification:
- No time extrapolation factor is needed since a chronic toxicity study is available.
- AF for interspecies differences (allometric scaling):
- 1.4
- Justification:
- The default allometric scaling factor for the differences between dogs and humans is used.
- AF for other interspecies differences:
- 1
- Justification:
- There is no evidence for species differences in the general mode of action or kinetics.
- AF for intraspecies differences:
- 5
- Justification:
- The default value for the relatively homogenous group "worker" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - workers
Occupational exposure to the test substance occurs mainly by dermal route and by inhalation exposure. Therefore two long term DNELs are calculated for workers. In view of the data used for evaluation, the "quality of whole database factor", "dose-response factor", "other interspecies differences" and "remaining uncertainties" are considered to amount each to a value of 1, and are thus not shown in the calculations presented below.
Hazard via inhalation route
Step 1:
Selection of the relevant dose descriptor (starting point):
For risk characterisation an
inhalation NOAEC was derived by route to route extrapolation. The oral
NOAEL of 1 mg/kg bw/day, obtained from a chronic toxicity testing in
dogs, was considered as key value for the chemical safety assessment and
therefore, most relevant starting point.
Step 2: Modification into a correct starting point:
The oral NO(A)EL was converted into an inhalation NO(A)EC according to the following formula assuming a daily exposure period of 8 hours during light activity:
Relevant dose descriptor (NO(A)EL): 1 mg/kg bw/day
Standard respiratory volume of the dog (sRVdog) for 8 hours: 0.16 m³/kg bw/day (Bide et al., 1997, pg viii)
Oral absorption of the dog / inhalation absorption of humans (ABSoral-dog / ABSinh-human): 0.5
Standard respiratory volume of humans (sRVhuman) for 8 hours: 6.7 m³
Worker respiratory volume (wRV) for 8 hours with light physical activity: 10 m³
NOAEC (Worker) inhalation = 1 mg/kg bw/day * 1/0.16 m³/kg bw/day * 6.7 m³/10 m³ * 0.5
= 2.09 mg/m³
Step 3: Use of assessment factors: 5
Interspecies: Respiratory interspecies differences are fully covered by the modification of the NOAEC
Intraspecies AF (worker): 5
Exposure duration AF: 1 (chronic study, OECD 452)
DNEL (Worker) inhalation = 2.09 mg/m³ / 5
= 0.418 mg/m³
In conclusion, long term systemic inhalation DNEL (worker) inhalation = 0.418 mg/m³
Hazard via dermal route:
Step 1: Selection of the relevant dose descriptor (starting point)
For risk characterisation an inhalation NOAEC was derived by route to route extrapolation. The oral NOAEL of 1 mg/kg bw/day, obtained from a chronic toxicity testing in dogs, was considered as key value for the chemical safety assessment and therefore, most relevant starting point.
Step 2: Modification into a correct starting point:
Using a conservative approach, a worker DNEL (long-term dermal exposure) is derived. Based on the physic-chemical properties dermal absorption is possible. According to “Guidance on information requirements and chemical safety assessment chapter R7c: Endpoint specific Guidance” especially the high water solubility of 164 g/L and the log Pow of 1.94 enable penetration. Further, the test substance is classified as a skin irritant, cat. 2 (H315) and the damage to the skin surface can enhance penetration. But based on the high molecular weight, between 470.22 to 498.77 g/mol, penetration of Olaflur will be limited. A dermal absorption of 10% of oral absorption is assumed as worst case.
NOAEC (Worker) dermal = 1 mg/kg bw/day / 0.1
= 10 mg/kg bw/day
Step 3: Use of assessment factors: 7
Interspecies AF, allometric scaling (dog to human): 1.4
Intraspecies AF (worker): 5
Exposure duration AF: 1 (chronic study, OECD 452)
DNEL (Worker) dermal = 10 mg/kg bw/day / 7
= 1.43 mg/kg bw/day
In conclusion, long term systemic dermal DNEL, workers = 1.43 mg/kg bw/day
Taking the acute oral toxicity data obtained into consideration, Olaflur might pose a minor risk to human health. In due consideration of the risk management measures suggested while handling Olaflur, immediate risk for human health (workers) can be excluded. Risk assessment of general public relevant only via cosmetic exposure, has been addressed in the respective safety dossier for cosmetic products and demonstrated that no risk for consumers (expected via cosmetic formulation) are to be expected.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.104 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- Overall assessment factor (AF):
- 10
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 1.04 mg/m³
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 1
- Justification:
- No time extrapolation factor is needed since a chronic toxicity study is available.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Respiratory interspecies differences are fully covered by the factors used for route to route extrapolation.
- AF for other interspecies differences:
- 1
- Justification:
- There is no evidence for species differences in the general mode of action or kinetics.
- AF for intraspecies differences:
- 10
- Justification:
- The default value for the relatively homogenous group "general population" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.71 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- Overall assessment factor (AF):
- 14
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 10 mg/kg bw/day
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 1
- Justification:
- No time extrapolation factor is needed since a chronic toxicity study is available.
- AF for interspecies differences (allometric scaling):
- 1.4
- Justification:
- The default allometric scaling factor for the differences between dogs and humans is used.
- AF for other interspecies differences:
- 1
- Justification:
- There is no evidence for species differences in the general mode of action or kinetics.
- AF for intraspecies differences:
- 10
- Justification:
- The default value for the relatively homogenous group "general population" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.07 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 14
- Dose descriptor starting point:
- NOAEL
- Value:
- 1 mg/kg bw/day
- AF for dose response relationship:
- 1
- Justification:
- The dose response relationship is considered unremarkable, therefore no additional factor is used.
- AF for differences in duration of exposure:
- 1
- Justification:
- No time extrapolation factor is needed since a chronic toxicity study is available.
- AF for interspecies differences (allometric scaling):
- 1.4
- Justification:
- The default allometric scaling factor for the differences between dogs and humans is used.
- AF for other interspecies differences:
- 1
- Justification:
- There is no evidence for species differences in the general mode of action or kinetics.
- AF for intraspecies differences:
- 10
- Justification:
- The default value for the relatively homogenous group "general population" is used.
- AF for the quality of the whole database:
- 1
- Justification:
- The quality of the whole data base is considered to be sufficient and uncritical.
- AF for remaining uncertainties:
- 1
- Justification:
- The approach used for DNEL derivation is conservative. No further assessment factors are required.
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - General Population
In view of the data used for evaluation, the "quality of whole database factor", "dose-response factor", "other interspecies differences" and "remaining uncertainties" are considered to amount each to a value of 1, and are thus not shown in the calculations presented below.
Hazard via inhalation route
Step 1:
Selection of the relevant dose descriptor (starting point):
For risk characterisation an
inhalation NOAEC was derived by route to route extrapolation. The oral
NOAEL of 1 mg/kg bw/day, obtained from a chronic toxicity testing in
dogs, was considered as key value for the chemical safety assessment and
therefore, most relevant starting point.
Step 2: Modification into a correct starting point:
Relevant dose descriptor (NO(A)EL): 1 mg/kg bw/day
Standard respiratory volume of the dog (sRVdog) for 24 hours: 0.48 m³/kg bw/day (Bide et al, 1997)
Oral absorption of the dog / inhalation absorption of humans (ABSoral-dog / ABSinh-human): 0.5
NOAEC (Worker) inhalation = 1 mg/kg bw/day * 1/0.48 m³/kg/ bw/day * 0.5
= 1.04 mg/m³
Step 3: Use of assessment factors: 10
Interspecies: Respiratory interspecies differences are fully covered by the modification of the NOAEC
Intraspecies AF (general population): 10
Exposure duration AF: 1 (chronic study, OECD 452)
DNEL (general population) inhalation = 1.04 mg/m³ / 10
= 0.104 mg/m³
In conclusion, long term systemic inhalation DNEL (general population) inhalation = 0.104 mg/m³
Hazard via dermal route:
Step 1: Selection of the relevant dose descriptor (starting point)
For risk characterisation an inhalation NOAEC was derived by route to route extrapolation. The oral NOAEL of 1 mg/kg bw/day, obtained from a chronic toxicity testing in dogs, was considered as key value for the chemical safety assessment and therefore, most relevant starting point.
Step 2: Modification into a correct starting point:
Using a conservative approach, a general population DNEL (long-term dermal exposure) is derived. Based on the physical-chemical properties dermal absorption is possible. According to “Guidance on information requirements and chemical safety assessment chapter R7c: Endpoint specific Guidance” especially the high water solubility of 164 g/L and the log Pow of 1.94 enable penetration. Further, the test substance is classified as a skin irritant, cat. 2 (H315) and the damage to the skin surface can enhance penetration. But based on the high molecular weight, between 470.22 to 498.77 g/mol, penetration of Olaflur will be limited. A dermal absorption of 10% of oral absorption is assumed as worst case.
NOAEC (general population) dermal = 1 mg/kg bw/day / 0.1
= 10 mg/kg bw/day
Step 3: Use of assessment factors: 14
Interspecies AF, allometric scaling (dog to human): 1.4
Intraspecies AF (general population): 10
Exposure duration AF: 1 (chronic study, OECD 452)
DNEL (general population) dermal = 10 mg/kg bw/day / 14
= 0.71 mg/kg bw/day
In conclusion, long term systemic dermal DNEL, general population = 0.71 mg/kg bw/day
Hazard via oral route:
Step 1: Selection of the relevant dose descriptor (starting point)
The oral repeated-dose study in rats/dogs performed according to OECD guideline 452 is selected for DNEL derivation. In this study, the oral NOAEL in rats and dogs is 1 mg/kg bw/day.
Step 2: Modification into a correct starting point:
Not required.
Step 3: Use of assessment factors: 14
Interspecies AF, allometric scaling (dog to human): 1.4
Intraspecies AF (general population): 10
Exposure duration AF: 1 (chronic study, OECD 452)
DNEL (general population) oral = 1 mg/kg bw/day / 14
= 0.07 mg/kg bw/day
In conclusion, long term systemic oral DNEL, general population = 0.07 mg/kg bw/day
Taking the acute oral toxicity data obtained into consideration, Olaflur might pose a minor risk to human health. Risk assessment of general public relevant only via cosmetic exposure, has been addressed in the respective safety dossier for cosmetic products and demonstrated that no risk for consumers (expected via cosmetic formulation) are to be expected.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.